Android app on Google Play

CVS Caremark (CVS) Tops Q4 EPS by 4c; Guides FY13 In-Line

February 6, 2013 7:02 AM EST Send to a Friend
CVS Caremark (NYSE: CVS) reported Q4 EPS of $1.14, $0.04 better than the analyst estimate of $1.10. Revenue for the quarter came in at $31.4 billion versus the consensus estimate of $31.13 billion.

CVS Caremark sees FY2013 EPS of $3.86-4.00, versus the consensus of $3.94.

For earnings history and earnings-related data on CVS Caremark (CVS) click here.

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Earnings

Related Entities


Add Your Comment